Skip to main content

Quidel Corporation (QDEL)

NASDAQ: QDEL · IEX Real-Time Price · USD
128.99
+0.75 (0.59%)
After-hours:Oct 15, 2021 7:53 PM EDT
128.24
-6.77 (-5.01%)
At close: Oct 15, 4:00 PM
Market Cap5.34B
Revenue (ttm)1.84B
Net Income (ttm)899.56M
Shares Out41.69M
EPS (ttm)20.90
PE Ratio6.14
Forward PE20.33
Dividendn/a
Ex-Dividend Daten/a
Volume698,628
Open134.57
Previous Close135.01
Day's Range128.07 - 135.84
52-Week Range103.31 - 288.70
Beta-0.10
AnalystsBuy
Price Target135.50 (+5.7%)
Est. Earnings DateOct 28, 2021

About QDEL

Quidel Corporation develops, manufactures, and markets diagnostic testing solutions for applications in infectious diseases, cardiology, thyroid, women's and general health, eye health, gastrointestinal diseases, and toxicology worldwide. It offers Sofia and Sofia 2 fluorescent immunoassay systems; QuickVue, a lateral flow immunoassay products; and InflammaDry and AdenoPlus, a POC products to detect infectious and inflammatory diseases and conditions of the eye. The company also provides Triage MeterPro, a portable testing platform that enables...

IndustryHealth Care Equipment & Supplies
Founded1979
CEODouglas Bryant
Employees1,370
Stock ExchangeNASDAQ
Ticker SymbolQDEL
Full Company Profile

Financial Performance

In 2020, QDEL's revenue was $1.66 billion, an increase of 210.66% compared to the previous year's $534.89 million. Earnings were $810.29 million, an increase of 1,011.18%.

Financial Statements

Analyst Forecast

According to 5 analysts, the average rating for QDEL stock is "Buy." The 12-month stock price forecast is 135.50, which is an increase of 5.66% from the latest price.

Price Target
$135.50
(5.66% upside)
Analyst Consensus: Buy

News

Quidel Blows Past Estimates for Q3 Revenue

COVID-19 testing volumes are up again.

2 days ago - The Motley Fool

Quidel Corporation (QDEL) Reports Solid Preliminary Q3 Revenues

Quidel's (QDEL) revenue growth in the third quarter is likely to have been boosted by robust sales of its SARS-related products.

5 days ago - Zacks Investment Research

Quidel Clocks Interim Q3 Sales Twice Of Wall Street Expected

Quidel Corporation (NASDAQ: QDEL) announced preliminary estimates for its Q3 revenues are expected to rise between 6% and 7% Y/Y on COVID-19 assay sales. Related:   Quidel Stock Falls As Q2 Earnings Mis...

1 week ago - Benzinga

These 2 COVID-19 Stocks Could Boost the Market Friday

Thursday's gains could be just the beginning.

Other symbols:VXRT
1 week ago - The Motley Fool

Quidel Announces Preliminary Revenue for Fiscal Third Quarter 2021

SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced tod...

1 week ago - Business Wire

New Strong Sell Stocks for October 6th

EQX, LMNR, QDEL, CP, and KAR have been added to the Zacks Rank #5 (Strong Sell) List on October 6, 2021.

Other symbols:CPEQXKARLMNR
1 week ago - Zacks Investment Research

2 Growth Stocks to Buy if You're Worried COVID Is Here to Stay

These could be good hedges to help offset the pandemic-related risks.

Other symbols:PFE
2 weeks ago - The Motley Fool

Which Stocks Are Cheaper Than Google's Stock?

We believe that there are other stocks that are currently better valued than Alphabet (Google)'s stock. GOOG's current price-to-operating income ratio (P/EBIT) of 30.3x is much higher than levels of 14....

Other symbols:AIMCFLWSNXST
2 weeks ago - Forbes

Is A Fall Imminent For Quidel Stock After A 22% Rise In A Month?

A few months back we discussed that Quidel stock looks undervalued at levels of around $108, based on the testing demand and the company's future growth prospects. QDEL stock has since rallied 36% to $1...

4 weeks ago - Forbes

3 Diagnostics Stocks in Focus on Biden's Delta Variant Mandate

Stocks like Quest Diagnostics (DGX), Quidel Corporation (QDEL) and LabCorp (LH) are the right picks now, thanks to rising COVID-19 testing demand.

Other symbols:ABTDGXLHQGEN
1 month ago - Zacks Investment Research

My Fat-Margin Stocks Returned 78% Last Year

It's been a great year for stocks with fat profit margins.

Other symbols:AMATCSCOEAGBLREGNTROW
1 month ago - GuruFocus

Quidel's (QDEL) QuickVue OTC COVID-19 Test Now Widely Available

In-store and online availability of Quidel's (QDEL) QuickVue OTC COVID-19 Test is expected to meet the rising COVID-19 testing needs across the United States.

1 month ago - Zacks Investment Research

Why Shares of Quidel Surged 10% This Week

Demand for its COVID tests are rising with cases.

1 month ago - The Motley Fool

Quidel To Bring OTC COVID-19 Antigen Test To CVS Pharmacy

Quidel Corporation's (NASDAQ: QDEL) non-prescription QuickVue At-Home OTC COVID-19 Test will be available next week at CVS Pharmacy locations across the U.S. and online at cvs.com. CVS Pharmacy is a par...

Other symbols:CVS
1 month ago - Benzinga

Quidel to Bring QuickVue® At-Home OTC COVID-19 Tests To CVS Pharmacy

SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced in ...

1 month ago - Business Wire

LivLyme Foundation Founder Olivia Goodreau to Discuss Perils of Lyme Disease in Free Webinar Hosted by Industry-Leadi...

SAN DIEGO--(BUSINESS WIRE)-- #Fishing--LivLyme Foundation Founder Olivia Goodreau to discuss her journey with Lyme and the importance of early testing as part of webinar to be held Aug. 19

2 months ago - Business Wire

Why Quidel Stock Was Falling on Friday

The company's Q2 headline numbers were nowhere near analyst estimates.

2 months ago - The Motley Fool

Quidel (QDEL) Q2 Earnings Fall Shy of Estimates, Margins Down

Quidel's (QDEL) dismal Q2 performance stems from lower revenues across majority of its product categories.

2 months ago - Zacks Investment Research

Quidel Stock Falls As Q2 Earnings Miss Street Estimates On Lower COVID-19, Influenza Product Sales

Quidel Corporation (NASDAQ: QDEL) reported after the close of the market Thursday that its second-quarter revenues fell 12% Y/Y to $176.6 million, below the consensus of $194.5 million. The decline is a...

2 months ago - Benzinga

Quidel (QDEL) Q2 Earnings Miss Estimates

Quidel (QDEL) delivered earnings and revenue surprises of -37.50% and 1.91%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

2 months ago - Zacks Investment Research

Quidel Reports Second Quarter 2021 Financial Results

SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today financia...

2 months ago - Business Wire

Quidel (QDEL) to Report Q2 Earnings: What's in the Offing?

Quidel (QDEL) is likely to have registered solid product sales during Q2 which are likely to have driven its overall top line.

2 months ago - Zacks Investment Research

Earnings Preview: Quidel (QDEL) Q2 Earnings Expected to Decline

Quidel (QDEL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

2 months ago - Zacks Investment Research

3 Reasons I Gave Up on Quidel

The company's next earnings report could be another disappointment.

2 months ago - The Motley Fool

Quidel Announces Agreement With Beckman Coulter That Terminates Ongoing Litigation and Transitions BNP Business to Be...

SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, today announc...

2 months ago - Business Wire